Corsair Capital Management »

Achilles Therapeutics shares owned by Corsair Capital Management

Quarter-by-quarter ownership of Achilles Therapeutics (ACHL) shares owned by Corsair Capital Management from 13F filings

Historical chart of Corsair Capital Management investment in Achilles Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Achilles Therapeutics held by Corsair Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Achilles Therapeutics by Corsair Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $20k 20k 1.02

More positions owned by Corsair Capital Management

Vertiv Holdings Com Cl A (VRT)
Mirion Technologies Com Cl A (MIR)
Laureate Education Common Stock (LAUR)
Godaddy Cl A (GDDY)
Limbach Hldgs (LMB)
Willscot Hldgs Corp Com Cl A (WSC)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spx Corp (SPXC)
Api Group Corp Com Stk (APG)
Aon Shs Cl A (AON)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Churchill Downs (CHDN)
Microsoft Corporation (MSFT)
S&p Global (SPGI)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Corsair Capital Management

Top funds holding Achilles Therapeutics

Syncona Portfolio
BML Capital Management
Fcpm Iii Services B.v.
Redmile Group
Vestal Point Capital
Ikarian Capital
Siren
Renaissance Technologies
Acadian Asset Management
Two Sigma Advisers
Geode Capital Management
Two Sigma Investments
Corsair Capital Management
Baader Bank
Susquehanna International

View all funds holding Achilles Therapeutics